Clinical Trials in New York

Showing 17861-17880 of 22,668 trials

Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma

NCT00002501

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of cyclophosphamide and filgrastim in treating patients with stage IV, relapsed, or refractory low-grade follicular non-Hodgkin's lymphoma.

Lymphoma

Alliance for Clinical Trials in Oncology29 participantsStarted Oct 1992

Chicago, Illinois, United States • Iowa City, Iowa, United States • Baltimore, Maryland, United States +12 more locations

COMPLETEDPhase 4< 1 mile

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

NCT00087607

This study will examine the viral kinetics and pharmacokinetics of Pegasys plus ribavirin and PEG-Intron plus ribavirin in interferon-naive patients with CHC. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.

Hepatitis C, Chronic

Hoffmann-La Roche385 participantsStarted Jan 2004

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Sacramento, California, United States +38 more locations

Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

Find Trials by Condition in New York

Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova

Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients

Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer

Expanded Access Program for Maraviroc At Multiple Centers

Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer

Talc in Treating Patients With Malignant Pleural Effusion

6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission

Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder

Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer

A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe Symptoms

A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia